Gene Mutations as Emerging Biomarkers and Therapeutic Targets for Relapsed Acute Myeloid Leukemia

It is believed that there are key differences in the genomic profile between adult and childhood acute myeloid leukemia (AML). Relapse is the significant contributor of mortality in patients with AML and remains as the leading cause of cancer death among children, posing great challenges in the trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Aziz, Habsah, Ping, Chow Y., Alias, Hamidah, Ab Mutalib, Nurul-Syakima, Jamal, Rahman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725465/
https://www.ncbi.nlm.nih.gov/pubmed/29270125
http://dx.doi.org/10.3389/fphar.2017.00897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725465/
https://www.ncbi.nlm.nih.gov/pubmed/29270125
http://dx.doi.org/10.3389/fphar.2017.00897

Ejemplares similares